Objective To assess the prevalence and the profile of adverse events (AE) of natalizumab in patients with multiple sclerosis (MS). Methods Data collection from neurologists attending to patients with MS at specialized units in Brazil. Results Data from 103 patient...
主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Academia Brasileira de Neurologia (ABNEURO)
2013-03-01
|
シリーズ: | Arquivos de Neuro-Psiquiatria |
主題: | |
オンライン・アクセス: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013000300137&lng=en&tlng=en |